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1. Introduction 
Rat tissues contain four hexokinase isoenzymes 
which are present in differing proportions in the 
various tissues. Each of the low-KM hexokinase 
types (EC 2.7.1 .l), designated I, II and III, has been 
partially purified from one or more rat tissues [ 1 ] 
but of these only type I from rat brain has been 
purified to homogeneity [2]. Recently a low yield 
preparation has been reported of rat hepatic glucokin- 
ase (EC 2.7.1.2) sometimes also called type IV hexo- 
kinase, which exhibits a high KM for glucose and a 
narrower substrate specificity than the other hexokin- 
ases [3]. The purification of hexokinase types II-IV 
by conventional methods has proved to be difficult 
due to the small qumtities available from the tissues 
and their inherent instability. 
A high yield preparation of homogeneous gluco- 
kinase from rat liver has recently been achieved by 
exploiting affinity chromatography on an agarose- 
N-(6-aminohexanoyl)-2-amino-2-deoxy-D-gluco- 
pyranose matrix [4-61. In this report we describe 
how such an affinity chromatographic method can 
be utilized along with more conventional techniques 
in order to prepare homogeneous type II hexokinase 
from rat skeletal muscle in high yield. The enzyme 
has a polypeptide chain mol. wt of 96 000. Amino 
acid analysis reveals similarities between the composi- 
tions of the hexokinase isozymes types 1, II and IV 
(glucokinase) which may have evolutionary significance. 
2. Materials and methods 
Hexokinase activity was determined as described 
by Holroyde et al. [5]. A unit of hexokinase activity 
North-Holland Publishing Company - Amsterdam 
is defined as that which catalyses the formation of 
1 pmol of glucose B-phosphate/mm at 30°C. 
Determination of protein concentration was by the 
turbidimetric microtannin method of Mejbaum- 
Katzenellenbogen and Dobryszycka [7]. The enzyme 
was concentrated by ultrafiltration at 4°C using an 
Amicon TCF-10 ultrafdtrator fitted with a UM 20E 
membrane. 
2.1. Preparation of muscle extracts 
Minced rat muscle from 50 rats (1250 g) was 
homogenized for 2 min at 4°C with 2 volumes of 
20 mM potassium phosphate buffer, pH 7.0, 
containing 10 mM glucose, 0.5 mM EDTA, 0.5 mM 
dithiothreitol and 5% (v/v) glycerol. The extract was 
centrifuged at 22 000 g for 30 min and the super- 
natant filtered through glass-wool and re-adjusted to 
pH 7.0 with 2 N KOH. 
2.2. heparation of affinity column 
N-(6-aminohexanoyl)-2-amino-2-deoxy-D-glucopyran- 
ose was prepared [5] and coupled to CNBr-activated 
Sepharose4B essentially as described by Axen et al. 
[8] under the conditions given by Trayer et al. [9] 
at a ligand concentration of 8 pmol ligand per g wet 
packed gel. This was diluted one-fold with unsubstitut- 
ed Sepharose4B prior to use. 
2.3. Vltracentrifugation 
Sedimentation equilibrium studies were performed 
in a Spinco Model E ultracentrifuge equipped with 
Rayleigh interference optics. The high speed method 
of Yphantis [lo] was used. Relatively high rotor 
speeds (27 670 rev/mm) and low protein concentra- 
tions (0.3 mg per ml) were used to ensure that the 
meniscus concentration was effectively zero. All runs 
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were performed in 20 mM triethanolamine-HCl 
buffer, pH 7.0, containing 0.3 M KCl, 1 mM EDTA, 
0.5 mM dithiothreitol, 50 mM glucose and 5% (v/v) 
glycerol. 
2.4. Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis in the presence 
of sodium dodecyl sulphate was carried out by the 
method of Weber and Osborn [ 1 l] . 
3. Results and discussion 
3.1. Purification of hexokinase type II 
Table 1 summarizes the purification procedure 
used. The crude muscle extract, after centrifugation, 
was absorbed batchwise on the DEAE-cellulose which 
was collected and washed on a Buchner funnel under 
suction before packing into a column. Fig. 1 (a) 
describes how this column was developed. The active 
fractions eluting under the KC1 gradient were pooled 
and applied to DEAE-Sephadex operated as shown in 
fig. l(b). This second anion exchange column offered 
an additional five-fold purification. The key to the 
purification scheme, however, was affinity chromato- 
graphy on the Sepharose-glucosamine derivative 
(fig.2). This resulted in another 50-fold purification 
(table 1) and the polyacrylamide gels (run in the 
presence of sodium dodecyl sulphate) show the 
hexokinase as the major component for the first time. 
The concentration of KC1 used to wash this column 
(120 mM) is fairly critical and dependent upon the 
ligand concentration attached to the Sepharose. If too 
high a concentration of KC1 in the wash or too low 
Table 1 
Purification scheme for rat skeletal muscle hexbkinase II 
Step Stage Volume Protein 
concentration 
Activity Total 
activity 
Yield Specific 
activity 
Fold 
purification 
(ml) (mdml) (units/ml) (units) (%) (units/mg of 
protein) 
Extraction and 
centrifugation 
DEAE-Cellulose 
DEAE-Sephadex 
Affinity column 
Sephadex C-200 
Concentration 
2300 66 0.42 1000 100 0.007 
356 4.7 2.75 980 98 0.6 90 
280 0.8 2.50 700 70 3.1 470 
138 0.03 4.35 600 60 145 21,000 
146 0.01 3.37 490 49 210 30,000 
16.0 0.14 30 480 48 210 30,000 
The results presented below are taken from a typical preparation starting with the skeletal muscle of 50 rats. 
Sodium dodecyl sulphate - polyacrylamide gel electrophoresis after Step: 
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Fig.1. (a) Chromatography of extract on DEAE-cellulose. 
After absorption on to the cellulose, the column material was 
packed into a column (25 X 4.5 cm) and washed with the 
running buffer, i.e. 20 mM potassium phosphate pH 7.0, 
containing 100 mM glucose, 1 mM EDTA, 0.5 mM dithio- 
threitol and 5% (v/v) glycerol. The column was developed by 
a linear gradient from 0 to 0.5 M KC3 over a total volume of 
2 litres. (b) Chromatography on DEAE-Sephadex equilibrated 
in 50 mM potassium phosphate buffer, pH 7.0, containing 
50 mM glucose, 1 mM EDTA, 0.5 mM dithiothreitol and 5% 
(v/v) glycerol. The active fractions from the DEAE-cellulose 
column were concentrated by ultrafiltration, dialysed against 
the above buffer and applied to a DEAE-Sephadex column 
(20 x 4.5 cm). After adequate washing this column was 
developed with a potassium phosphate gradient from 50 to 
500 mM (total volume 2 litre). Both columns were run at 
40 ml/h and 8 ml fractions were collected. 
a ligand concentration on the column is chosen then 
the enzyme will begin to leak from the column prior 
to introducing the glucose. The need for adjustment 
of ligand concentration on the Sepharose support to 
achieve maximum purification of hepatic glucokinase 
has already been discussed [5,6] and the same prin- 
ciples also apply to this related enzyme. 
The active fractions emerging from the affinity 
column were concentrated on a small DEAE-cellulose 
column [6] prior to gel filtration on Sephadex G-200. 
This column (90 X 3 cm) was operated in 20 mM 
triethanolamine-HCl buffer, pH 7.2, containing 100 
mM KCl, 100 mM glucose, 1 mM EDTA, 0.5 mM 
dithiothreitol and 5% (v/v) glycerol. The enzyme, 
Fraction No. 
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Fig.2. Affinity chromatography on Sepharose-N-(6-amino- 
hexanoyl)-2-amino-2-deoxy-D-glucopyranose (4 pmol/g wet 
wt. of Sepharose 4B). The active fractions from the DEAE- 
Sephadex column were concentrated by ultrafiltration and 
equilibrated with 20 mM triethanolamine-HCl buffer, pH 7.0, 
containing 50 mM KCl, 4 mM EDTA, 7.5 mM MgCl,, 0.5 mM 
dithiothreitol and 5% (v/v) glycerol by passing through 
Sephadex G-25. This pool was applied directly to the 
affinity column (35 X 3 cm) equilibrated in the above buffer 
and washed through with a further 250 ml of this buffer. At 
A, the KC3 concentration in this buffer was raised to 120 mM 
and at B, 200 mM glucose was also included. The column was 
operated at 40 ml/h and 6 ml fractions were collected. 
essentially homogeneous at this stage (table l), 
could be stored at 4°C in this buffer, after concentra- 
tion on a small DEAE-cellulose column as above, for 
several months without appreciable loss of activity. 
3.2. Properties of hexokinase type II 
Polyacrylamide gel electrophoresis of the hexo- 
kinase in the presence of sodium dodecyl sulphate 
showed a single component migrating with a mol. wt 
of 98 000 when compared to known standards. 
Sedimentation equilibrium measurements of the 
native enzyme in the presence of glucose gave a mol. 
wt. of 96 000. This value is the same as that obtained 
for the hexokinase type I isolated from rat brain [2], 
rat kidney (M. J. Holroyde and I. P. Trayer, unpublish- 
ed observations) and pig heart [ 131 but is twice that 
obtained for the rat liver type IV (glucokinase) iso- 
enzyme [6]. No evidence of high mol. wt. species was 
seen under the conditions used in these studies on the 
type II isoenzyme, even after prolonged ultracentrifu- 
gation (48 h). Glucose 6-phosphate, however, has 
been shown to favour dimer formation of the pig 
heart type I hexokinase [ 141. 
Initial velocity experiments of the muscle hexo- 
kinase indicated that the Michaelis constants for 
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Fig.3. Plots of the reciprocal initial velocity (v) with respect 
to (a) reciprocal of concentration of glucose in the presence 
of varying fixed concentrations (mM) of MgATP’- (concen- 
trations indicated by appropriate line) and (b) reciprocal con- 
centrations of Mg.ATP*- in the presence of varying fixed 
concentrations (mM) of glucose (concentrations indicated by 
appropriate line). 
MgATP’- and glucose were 1 .l 1 mM and 0.2 mM 
respectively (tig.3). The slightly different assay condi- 
tions almost certainly account for the minor differen- 
ces noted between our figures and those reported by 
others for impure preparations of the enzyme [ 1, 151. 
In table 2 the amino acid composition of rat muscle 
hexokinase, type II, is compared with published values 
for the rat brain type I isoenzyme [2] and rat hepatic 
glucokinase [6]. The similarities are quite striking and 
are emphasized when the ‘difference indices of compo- 
sitional relatedness’ of Metzger et al. [ 161 are calculat- 
ed. Despite the obvious limitations inherent in this 
type of analysis, it is tempting to speculate that the 
high mol. wt., low-KM mammalian hexokinases may 
have arisen by partial gene duplication from some 
primitive presumptive glucokinase-type enzyme. Any 
evolutionary relationships in this class of enzymes must, 
however, await sequence analysis. 
Table 2 
Amino acid composition of mammalian hexokinases 
Amino acid Rat brain 
type Ia 
Rat skeletal 
muscle type Hb 
Rat liver 
type IVc 
Aspartic acid 98 92 92 
Threonine 50 54 48 
Serine 48 52 62 
Glutamic acid 88 104 118 
Proline 36 26 28 
Glycine 80 86 80 
Alanine 48 66 60 
Valine 64 66 64 
Methionine 30 30 36 
Isoleucine 50 36 34 
Leucine 84 92 82 
Tyrosine 8 16 16 
Phenylalanine 36 36 36 
Histidine 18 23 22 
Lysine 60 52 50 
Arginine 54 56 56 
Amino acid analyses were performed as described by 
Wilkinson et al. [ 121. Duplicate samples were hydrolysed in 
6 N HCl under vacuum for 24 and 72 h. All figures are 
calculated as residues per 96 000 g. (NB mol. wt of the liver 
type IV isoenzyme (glucokinase) is 48 000 [6]). The Metzger 
‘difference indices of compositional relatedness’ [ 161 
between these enzymes are as follows: types I and II, 5.5; 
types II and IV, 3.4; and types I and IV, 4.5. 
aFrom Chou and Wilson [ 21. 
bFrom this study. 
‘From Holroyde et al. [6]. 
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